Kronik hepatit B hastalarında interferon alfa 2b+ lamivudin kombinasyon tedavisinin etkinliği
































































Hsia CC, Yuwen H, Tabor E (1996). Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet. 348: 625626.
Hyams KC (1989). Mosquito transmission of hepatitis B virus. Lancet. 889 893.
Ikeda T, Andrew M, Lever L, Howard C, Thomas C (1986). Evidence for a deficiency of interferon production in patients with chronic hepatitis B infection acquired in adult life. Hepatology. 6: 962969.
Jaboli F, Fabbri C, Liva S et al (2003). Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe positive chronic hepatitis B: result of an open, controlled trial. World J Gastroenterelog. 9: 14911495.
Kalyoncu A, Tan D, Mırsal H et al (2005). Major depressive disorder with psychotic features induced by interferon-alfa treatment for hepatitis C in a polydrug abuser. Psychopharm. 102105.
.Keffe EB, Douglas TD, Han SB ve ark (2004). A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An UpdateAmerika Clin Gastroenterol end hepatol. 2: 87104.



58. SAYFAYA BENZER SAYFALAR

Kronik hepatit C hastalarında hepatit B virüs enfeksiyonu ile karşılaşma sıklığı The incidance of - Sayfa 77
57. Keeffe E, Dieterich D, Han S, Jacobson İ, Martin P, Schiff E, Tobias H, Wright T. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clinical Gasroenterology and Hepatology 4: 936-962, 2006. 58. Sünbül M, Leblecioğlu H. Kronik hepatit C tedavisinde PEG-İnterferon kullanımı. Flora 8: 3-16, 2003. 59. Kozlowski A, Haris JM. Improvements in protei...
Kronik HBEAg negatif ve pozitif hepatit B hastalarında Pegile interferon Alfa 2 A (180 Mcg/hafta) tedavisinin adefovir dipivoksil(10 mg/gün) tedavisi ile karşılaştırılması - Sayfa 98
84 46. Sünbül M, Leblecioğlu H. Kronik hepatit C tedavisinde PEG-İnterferon kullanımı. Flora 2003; 8(Ek 1):3-16. 47. Gillian M.K, Greg L.P. Peginterferon alfa 2a plus ribavirin. A review of its use in the management of patients with chronic hepatitis C and persistently normal ALT levels.Drugs 2005;65(4):521-536. 48. Cooksley WG, Piratvisuth T, Lee SD, Mahachai V, Chao YC, Tanwandee T, et al. P...
Kronik hepatit C hastalarında pegile İnterferon + Ribavirin tedavisine yanıtta etkili olabilecek tedavi öncesi parametrelerin - Sayfa 82
107. Poynard T, Imbert Bismut F, Munteanu M, Ratziu V. FibroTest – FibroSURE: towards a universal biomarker of liver fibrosis. Expert Rev. Mol. Diagn. 2005; 5:15-21. 108. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised tiral of interferon alfa 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa 2b plus placebo for 48 weeks for treatment of chronic ...

58. SAYFADAKI ANAHTAR KELIMELER

treatment
hepatitis
virus
infection
chronic
with


58. SAYFA ICERIGI

Hsia CC, Yuwen H, Tabor E (1996). Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet. 348: 625626.
Hyams KC (1989). Mosquito transmission of hepatitis B virus. Lancet. 889 893.
Ikeda T, Andrew M, Lever L, Howard C, Thomas C (1986). Evidence for a deficiency of interferon production in patients with chronic hepatitis B infection acquired in adult life. Hepatology. 6: 962969.
Jaboli F, Fabbri C, Liva S et al (2003). Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe positive chronic hepatitis B: result of an open, controlled trial. World J Gastroenterelog. 9: 14911495.
Kalyoncu A, Tan D, Mırsal H et al (2005). Major depressive disorder with psychotic features induced by interferon-alfa treatment for hepatitis C in a polydrug abuser. Psychopharm. 102105.
.Keffe EB, Douglas TD, Han SB ve ark (2004). A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An UpdateAmerika Clin Gastroenterol end hepatol. 2: 87104.

İlgili Kaynaklar







single.php